AtriCure, Inc. (ATRC) vs Stevanato Group S.p.A. (STVN)
- AtriCure, Inc. ATRC 60.70 −7.37%
- Stevanato Group S.p.A. STVN 13.12 −2.38%
AtriCure, Inc. and Stevanato Group S.p.A. are both Medical Instruments & Supplies companies. Stevanato Group S.p.A. is the larger, with a market value of $3.6B against $3.1B — 1.2× the size. Stevanato Group S.p.A. trades at the lower P/E: 22.4× against 199×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.8% against 11.6%. Stevanato Group S.p.A. has the higher net margin (11.2% vs 2.52%) and the higher return on invested capital (6.71% vs 2.61%). Across the 21 metrics below, Stevanato Group S.p.A. leads on 12 and AtriCure, Inc. on 9.
Valuation
Profitability
| Metric | ATRC | STVN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.74% | 29.11% | 53.60% |
| Operating margin | 2.89% | 16.60% | 1.97% |
| Net margin | 2.52% | 11.21% | 0.00% |
| Free cash flow margin | 8.98% | (0.61%) | 2.36% |
| Return on equity | 2.95% | 9.22% | 0.00% |
| Return on assets | 2.20% | 5.50% | 0.00% |
| Return on invested capital | 2.61% | 6.71% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack